Back to Search
Start Over
Increasing incidence of acute autoimmune hepatitis: a nationwide survey in Japan.
- Source :
-
Scientific reports [Sci Rep] 2020 Aug 28; Vol. 10 (1), pp. 14250. Date of Electronic Publication: 2020 Aug 28. - Publication Year :
- 2020
-
Abstract
- The Japanese diagnostic guidelines for autoimmune hepatitis (AIH) were proposed in 2014. This study aimed to determine the trends and characteristics of AIH based on a Japanese nationwide survey. Data for 796 patients who were newly diagnosed with AIH from 2014 to 2017 were collected from January to March, 2019 from 54 hospitals throughout Japan. Clinical characteristics, including treatment, were compared with those reported in a prior 2015 survey. The population had a median age of 63 years at diagnosis, and the male to female ratio was 1:5.3. The numbers of women was significantly lower in this survey than in the 2015 survey. Moreover, the incidence of AIH with histological acute hepatitis increased significantly from 11.0 to 21.7%. The changes in the laboratory findings, such as in transaminase and immunoglobulin G levels and antinuclear antibody titers, as well as in prednisolone treatment, reflected an increasing incidence of acute AIH. The clinical characteristics of AIH changed rapidly, in parallel with the increasing incidence of acute AIH. The elucidation and diagnosis of AIH with acute hepatitis are important in the management of AIH.
- Subjects :
- Acute Disease
Adult
Aged
Alanine Transaminase analysis
Antibodies, Antinuclear analysis
Bilirubin analysis
Female
Hepatitis, Autoimmune diagnosis
Humans
Immunoglobulin G analysis
Incidence
Japan epidemiology
Liver pathology
Male
Middle Aged
Prednisolone therapeutic use
Surveys and Questionnaires
Hepatitis, Autoimmune epidemiology
Subjects
Details
- Language :
- English
- ISSN :
- 2045-2322
- Volume :
- 10
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Scientific reports
- Publication Type :
- Academic Journal
- Accession number :
- 32859968
- Full Text :
- https://doi.org/10.1038/s41598-020-71296-0